Background: Women of all income levels experience domestic violence (DV). Primary health-care providers are able to screen women early and provide services or referrals; however, regular DV screening rarely occurs in the US. We investigated whether implicit bias based on patient population income level could be influencing provider practices in California. Methods: Data for this study were drawn from a self-administered survey conducted from October 2013 to March 2014. Providers (n = 152) were included if they worked in primary care and provided information on the predominant income of their patients. The survey included questions on provider demographics, screening practices, and number of female victims identified. Results: Providers serving low-income patient populations (LIPPs) or higher-income patient populations had equivalent training and knowledge about DV. However, DV screening practices (e.g., screening more often, at a younger age, and giving a screening question for DV) and outcomes (DV victims identified) varied significantly by patient population income level (P < 0.01). Working with low-income patients and engaging in universal screening practices both predicted more victim identification (P < 0.01). Conclusions: Implicit bias appears to influence clinicians’ screening practices, with those serving LIPPs being more likely to screen regardless of training or knowledge. If DV screening in primary care occurred more regularly, it would yield more detection of victims at all income levels. Training and self-reflection could combat implicit bias, as well as written policies and standardized procedures to encourage universal screening practices by clinicians irrespective of the income level of their patient populations.
Disorganized Diseases: Are they a Simple Explosion of Random Energy and there...asclepiuspdfs
Objective: The study has two objectives: (1) To determine the prevailing characteristics of a given set of patients with “disorganized disease” and (2) to determinate the prevailing outcomes for these patients in family medicine to assess their implications for decision-making. Participants and Methods: A qualitative, longitudinal, and retrospective cases series study based on a single cohort was carried out. Analyses based on a retrospective study of case records from June to October 2017, in a family medicine office in the Health Center Santa Maria de Benquerencia, Toledo, Spain. A convenience sample was selected consisting of patients who consulted during that period and who met the criteria for entering the study. These cases were considered in the epidemiological term as index cases, which means that beyond these the study should be expanded. Hence, in addition, using a technique of snowball “mental” or “astute clinical observation” others patients attended previously were included until the saturation of the data. The cases were described in short case reports. An analysis of the content of these reports was carried out, defining categories of qualitative data. The results were interpreted, and a generalization was drawn from these cases.
Rethinking, rebuilding psychosocial care for cancer patientsJames Coyne
Presented as the 8th Trevor Anderson Psycho-Oncology Lecture, September 8, 2014, Melbourne, Australia.
Discusses how psychosocial care for cancer patients needs to be reorganized so that a broader range of cancer patients are served. Routine screening for distress is unlikely to be an efficient means of countering tendencies of cancer care more generally becoming more organized around time efficiency and billable procedures. Psychosocial care for many cancer patients involves discussions, negotiations, and care coordination they cannot be well fit into the idea of a counseling session. The unsung heroes of providing such care are underappreciated social workers and oncology nurses.
The term diagnosis is a statement or conclusion regarding the nature of phenomenon.
A nursing diagnosis is a clinical judgment concerning a human response to health conditions/life processes, or a vulnerability for that response, by an individual, family, group or community. A nursing diagnosis provides the basis for selection of nursing interventions to achieve outcomes for which the nurse has accountability.
Multiple Chemical Sensitivities - A Proposed Care Model v2zq
Multiple Chemical Sensitivities - A Proposed Care Model - Resources for Healthy Children www.scribd.com/doc/254613619 - For more information, Please see Organic Edible Schoolyards & Gardening with Children www.scribd.com/doc/254613963 - Gardening with Volcanic Rock Dust www.scribd.com/doc/254613846 - Double Food Production from your School Garden with Organic Tech www.scribd.com/doc/254613765 - Free School Gardening Art Posters www.scribd.com/doc/254613694 - Increase Food Production with Companion Planting in your School Garden www.scribd.com/doc/254609890 - Healthy Foods Dramatically Improves Student Academic Success www.scribd.com/doc/254613619 - City Chickens for your Organic School Garden www.scribd.com/doc/254613553 - Huerto Ecológico, Tecnologías Sostenibles, Agricultura Organica www.scribd.com/doc/254613494 - Simple Square Foot Gardening for Schools - Teacher Guide www.scribd.com/doc/254613410 - Free Organic Gardening Publications www.scribd.com/doc/254609890 ~
Disorganized Diseases: Are they a Simple Explosion of Random Energy and there...asclepiuspdfs
Objective: The study has two objectives: (1) To determine the prevailing characteristics of a given set of patients with “disorganized disease” and (2) to determinate the prevailing outcomes for these patients in family medicine to assess their implications for decision-making. Participants and Methods: A qualitative, longitudinal, and retrospective cases series study based on a single cohort was carried out. Analyses based on a retrospective study of case records from June to October 2017, in a family medicine office in the Health Center Santa Maria de Benquerencia, Toledo, Spain. A convenience sample was selected consisting of patients who consulted during that period and who met the criteria for entering the study. These cases were considered in the epidemiological term as index cases, which means that beyond these the study should be expanded. Hence, in addition, using a technique of snowball “mental” or “astute clinical observation” others patients attended previously were included until the saturation of the data. The cases were described in short case reports. An analysis of the content of these reports was carried out, defining categories of qualitative data. The results were interpreted, and a generalization was drawn from these cases.
Rethinking, rebuilding psychosocial care for cancer patientsJames Coyne
Presented as the 8th Trevor Anderson Psycho-Oncology Lecture, September 8, 2014, Melbourne, Australia.
Discusses how psychosocial care for cancer patients needs to be reorganized so that a broader range of cancer patients are served. Routine screening for distress is unlikely to be an efficient means of countering tendencies of cancer care more generally becoming more organized around time efficiency and billable procedures. Psychosocial care for many cancer patients involves discussions, negotiations, and care coordination they cannot be well fit into the idea of a counseling session. The unsung heroes of providing such care are underappreciated social workers and oncology nurses.
The term diagnosis is a statement or conclusion regarding the nature of phenomenon.
A nursing diagnosis is a clinical judgment concerning a human response to health conditions/life processes, or a vulnerability for that response, by an individual, family, group or community. A nursing diagnosis provides the basis for selection of nursing interventions to achieve outcomes for which the nurse has accountability.
Multiple Chemical Sensitivities - A Proposed Care Model v2zq
Multiple Chemical Sensitivities - A Proposed Care Model - Resources for Healthy Children www.scribd.com/doc/254613619 - For more information, Please see Organic Edible Schoolyards & Gardening with Children www.scribd.com/doc/254613963 - Gardening with Volcanic Rock Dust www.scribd.com/doc/254613846 - Double Food Production from your School Garden with Organic Tech www.scribd.com/doc/254613765 - Free School Gardening Art Posters www.scribd.com/doc/254613694 - Increase Food Production with Companion Planting in your School Garden www.scribd.com/doc/254609890 - Healthy Foods Dramatically Improves Student Academic Success www.scribd.com/doc/254613619 - City Chickens for your Organic School Garden www.scribd.com/doc/254613553 - Huerto Ecológico, Tecnologías Sostenibles, Agricultura Organica www.scribd.com/doc/254613494 - Simple Square Foot Gardening for Schools - Teacher Guide www.scribd.com/doc/254613410 - Free Organic Gardening Publications www.scribd.com/doc/254609890 ~
Three hour slide deck for basics of palliative care including what is palliative care, symptom management (pain, dyspnea, nausea, constipation), goals-of-care, family meetings, comfort care, and issues around artificial nutrition.
The STUDY of the DISTRIBUTION & DETERMINANTS of HEALTH-RELATED STATES in specified POPULATIONS, and the application of this study to CONTROL of health problems.
Evaluations of and Interventions for Non Adherence to Oral Medications as a P...NiyotiKhilare
The focus of this presentation will be medical non-adherence as a psychosocial issue in diabetes. The presentation will also focus elaborately on empowerment as an intervention amongst other interventions.
Hospice & Palliative Care Missouri Health Net Aug 2009Christian Sinclair
Presentation to Missouri HealthNet (State Medicaid Program) about hospice and palliative care issues. Please see accompanying handout for facts presented in presentation.
Basics of palliative care including symptom management: pain, dyspnea, nausea and constipation; family meetings, goals-of-care, end-of-life care, and artificial nutrition.
Carle Palliative Care Journal Club 1/15/2020Mike Aref
A journal club review and criticism of J Natl Cancer Inst. 2019 Dec 17. pii: djz233. doi: 10.1093/jnci/djz233 Emergency Department Visits for Opioid Overdoses Among Patients with Cancer by Jairam V, Yang DX, Yu JB, Park HS.
Building the Evidence for Violence Prevention and Mitigation Interventions: A...JSI
A systematic review was conducted of peer-reviewed literature published between 2006 and 2017 to identify outcomes that lie along the pathway from interventions to outcomes. It was concluded that focusing on intermediate outcomes may help address measurement challenges and build a persuasive evidence base, critical to elevate violence in policy and practice change discussions and secure resources to prevent, address, and reduce the impact of violence.
This poster will be presented by Karuna Chibber at the 2018 American Public Health Association Conference in San Diego, CA.
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docxvickeryr87
2011; 33: e50–e56
WEB PAPER
The ethics of HIV testing and disclosure for
healthcare professionals: What do our future
doctors think?
JULIE M. AULTMAN1 & NICOLE J. BORGES2
1Northeastern Ohio Universities College of Medicine, USA, 2Wright State University Boonshoft School of Medicine, USA
Abstract
Aim: This study examined future medical professionals’ attitudes and beliefs regarding mandatory human immunodeficiency virus
(HIV) testing and disclosure.
Method: A total of 54 US medical students were interviewed regarding mandatory testing and disclosure of HIV status for both
patient and health care professional populations. Interviews were qualitatively analyzed using thematic analysis by the first author
and verified by the second author.
Results: Medical students considered a variety of perspectives, even placing themselves in the shoes of their patients or imagining
themselves as a healthcare professional with HIV. Mixed opinions were presented regarding the importance of HIV testing for
students coupled with a fear about school administration regarding HIV positive test results and the outcome of a student’s career.
Third- and fourth-year medical students felt that there should be no obligation to disclose one’s HIV status to patients, colleagues,
or employers. However, most of these students did feel that patients had an obligation to disclose their HIV status to healthcare
professionals.
Conclusion: This study gives medical educators a glimpse into what our future doctors think about HIV testing and disclosure, and
how difficult it is for them to recognize that they can be patients too, as they are conflicted by professional and personal values.
Introduction
The overall aim of this qualitative study is to gain a deeper
understanding of future doctors’ attitudes and beliefs regarding
mandatory human immunodeficiency virus (HIV) testing and
disclosure, and to explore current medical students’ personal
biases and stigmas surrounding HIV testing and disclosure.
Present and future doctors may face the challenges of having
to not only request that patients disclose their HIV status, but
also to decide whether to report one’s own HIV status to
patients, colleagues, and/or employing healthcare institutions.
By examining and identifying some of the beliefs and attitudes
surrounding such dilemmas, we believe this information can
be of help to medical educators as they work with medical
students and their clinical preceptors to resolve many of the
social and ethical problems associated with the stigma of HIV
disclosure, while improving the overall health of individuals
and communities. In addition to the presentation and analysis
of our data, we provide curriculum recommendations for
ethics education for HIV testing and disclosure for medical
students. First, we will provide descriptive background infor-
mation on HIV testing and disclosure.
HIV testing
In the United States, there are several private and public.
Three hour slide deck for basics of palliative care including what is palliative care, symptom management (pain, dyspnea, nausea, constipation), goals-of-care, family meetings, comfort care, and issues around artificial nutrition.
The STUDY of the DISTRIBUTION & DETERMINANTS of HEALTH-RELATED STATES in specified POPULATIONS, and the application of this study to CONTROL of health problems.
Evaluations of and Interventions for Non Adherence to Oral Medications as a P...NiyotiKhilare
The focus of this presentation will be medical non-adherence as a psychosocial issue in diabetes. The presentation will also focus elaborately on empowerment as an intervention amongst other interventions.
Hospice & Palliative Care Missouri Health Net Aug 2009Christian Sinclair
Presentation to Missouri HealthNet (State Medicaid Program) about hospice and palliative care issues. Please see accompanying handout for facts presented in presentation.
Basics of palliative care including symptom management: pain, dyspnea, nausea and constipation; family meetings, goals-of-care, end-of-life care, and artificial nutrition.
Carle Palliative Care Journal Club 1/15/2020Mike Aref
A journal club review and criticism of J Natl Cancer Inst. 2019 Dec 17. pii: djz233. doi: 10.1093/jnci/djz233 Emergency Department Visits for Opioid Overdoses Among Patients with Cancer by Jairam V, Yang DX, Yu JB, Park HS.
Building the Evidence for Violence Prevention and Mitigation Interventions: A...JSI
A systematic review was conducted of peer-reviewed literature published between 2006 and 2017 to identify outcomes that lie along the pathway from interventions to outcomes. It was concluded that focusing on intermediate outcomes may help address measurement challenges and build a persuasive evidence base, critical to elevate violence in policy and practice change discussions and secure resources to prevent, address, and reduce the impact of violence.
This poster will be presented by Karuna Chibber at the 2018 American Public Health Association Conference in San Diego, CA.
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docxvickeryr87
2011; 33: e50–e56
WEB PAPER
The ethics of HIV testing and disclosure for
healthcare professionals: What do our future
doctors think?
JULIE M. AULTMAN1 & NICOLE J. BORGES2
1Northeastern Ohio Universities College of Medicine, USA, 2Wright State University Boonshoft School of Medicine, USA
Abstract
Aim: This study examined future medical professionals’ attitudes and beliefs regarding mandatory human immunodeficiency virus
(HIV) testing and disclosure.
Method: A total of 54 US medical students were interviewed regarding mandatory testing and disclosure of HIV status for both
patient and health care professional populations. Interviews were qualitatively analyzed using thematic analysis by the first author
and verified by the second author.
Results: Medical students considered a variety of perspectives, even placing themselves in the shoes of their patients or imagining
themselves as a healthcare professional with HIV. Mixed opinions were presented regarding the importance of HIV testing for
students coupled with a fear about school administration regarding HIV positive test results and the outcome of a student’s career.
Third- and fourth-year medical students felt that there should be no obligation to disclose one’s HIV status to patients, colleagues,
or employers. However, most of these students did feel that patients had an obligation to disclose their HIV status to healthcare
professionals.
Conclusion: This study gives medical educators a glimpse into what our future doctors think about HIV testing and disclosure, and
how difficult it is for them to recognize that they can be patients too, as they are conflicted by professional and personal values.
Introduction
The overall aim of this qualitative study is to gain a deeper
understanding of future doctors’ attitudes and beliefs regarding
mandatory human immunodeficiency virus (HIV) testing and
disclosure, and to explore current medical students’ personal
biases and stigmas surrounding HIV testing and disclosure.
Present and future doctors may face the challenges of having
to not only request that patients disclose their HIV status, but
also to decide whether to report one’s own HIV status to
patients, colleagues, and/or employing healthcare institutions.
By examining and identifying some of the beliefs and attitudes
surrounding such dilemmas, we believe this information can
be of help to medical educators as they work with medical
students and their clinical preceptors to resolve many of the
social and ethical problems associated with the stigma of HIV
disclosure, while improving the overall health of individuals
and communities. In addition to the presentation and analysis
of our data, we provide curriculum recommendations for
ethics education for HIV testing and disclosure for medical
students. First, we will provide descriptive background infor-
mation on HIV testing and disclosure.
HIV testing
In the United States, there are several private and public.
Effects of Community-Based Health WorkerInterventions to Imp.docxSALU18
Effects of Community-Based Health Worker
Interventions to Improve Chronic Disease
Management and Care Among Vulnerable
Populations: A Systematic Review
Kyounghae Kim, RN, MSN, Janet S. Choi, MPH, Eunsuk Choi, RN, PhD, MPH, Carrie L. Nieman, MD, MPH, Jin Hui Joo, MD, MA,
Frank R. Lin, MD, PhD, Laura N. Gitlin, PhD, and Hae-Ra Han, RN, PhD
Background. Community-based health workers (CBHWs) are frontline
public health workers who are trusted members of the community they
serve. Recently, considerable attention has been drawn to CBHWs in pro-
moting healthy behaviors and health outcomes among vulnerable pop-
ulations who often face health inequities.
Objectives. We performed a systematic review to synthesize evidence
concerning the types of CBHW interventions, the qualification and
characteristics of CBHWs, and patient outcomes and cost-effectiveness
of such interventions in vulnerable populations with chronic, non-
communicable conditions.
Search methods. We undertook 4 electronic database searches—PubMed,
EMBASE, Cumulative Index to Nursing and Allied Health Literature, and
Cochrane—and hand searched reference collections to identify randomized
controlled trials published in English before August 2014.
Selection. We screened a total of 934 unique citations initially for titles
and abstracts. Two reviewers then independently evaluated 166 full-
text articles that were passed onto review processes. Sixty-one studies
and 6 companion articles (e.g., cost-effectiveness analysis) met eligi-
bility criteria for inclusion.
Data collection and analysis. Four trained research assistants extracted
data by using a standardized data extraction form developed by the
authors. Subsequently, an independent research assistant reviewed
extracted data to check accuracy. Discrepancies were resolved through
discussions among the study team members. Each study was evaluated
for its quality by 2 research assistants who extracted relevant study
information. Interrater agreement rates ranged from 61% to 91% (av-
erage 86%). Any discrepancies in terms of quality rating were resolved
through team discussions.
Main results. All but 4 studies were conducted in the United States.
The 2 most common areas for CBHW interventions were cancer pre-
vention (n = 30) and cardiovascular disease risk reduction (n = 26). The
roles assumed by CBHWs included health education (n = 48), counseling
(n = 36), navigation assistance (n = 21), case management (n = 4), social
services (n = 7), and social support (n = 18). Fifty-three studies provided
information regarding CBHW training, yet CBHW competency evalua-
tion (n = 9) and supervision procedures (n = 24) were largely under-
reported. The length and duration of CBHW training ranged from 4
hours to 240 hours with an average of 41.3 hours (median: 16.5 hours) in
24 studies that reported length of training. Eight studies reported the
frequency of supervision, which ranged from weekly to monthly. There ...
Addressing Sexual Assault and Intimate Partner Violence in Medical Care and Education in the U.S. and Globally
Jennifer A. Wagman, PhD, MHS
April 13th, 2018
UCSD HIV & Global Health Rounds
Program evaluation: Philadelphia Fight’s Youth Health Empowerment Program (Y-...Antar T. Bush. MSW, MPH
HIV/AIDS has been serious public health issue facing the city of Philadelphia for the last two decades. According the AIDS Activities Coordinating Office, there are approximately 30,000 individuals living with HIV/AIDS in Philadelphia (AACO, 2012). This average is slightly higher than other major cities in the United States. AACO states the most vulnerable population is young men who have sex with men of color (MSM) between the ages of 15 and 25. This young population makes up for 56% of all new diagnosis of in the city (AACO, 2012). It is imperative for Philadelphia Fight to stay innovative with their approach to tackling sexual health issues that face this city. One major way Philadelphia Fight is addressing is epidemic is through opening the Youth Health Empowerment Project (Y-HEP).
New York State Drug Court Program: The
participant will be able to: Demonstrate the efficacy of
patient navigation in order to improve maternal/child
health outcomes and parenting skills for the court
involved population.
Global Medical Cures™ | HIV TESTING IN USA
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
Condoms as a harm reduction approach in prisonsErin Bortel
Keeping High-Impact Prevention at the forefront of our attention will guide administrators and policy-makers implementing harm reduction strategies in incarcerated settings to End AIDS in NYS by 2020.
Similar to Are Primary Care Clinicians Serving Low-Income Patients More Likely to Screen for Domestic Violence? (20)
Convalescent Plasma and COVID-19: Ancient Therapy Re-emergedasclepiuspdfs
Convalescent plasma has again re-emerged as a therapy during coronavirus disease (COVID-19) outbreaks currently use as a prophylactic or an interventional treatment in infected patients. Convalescent plasma has been used in the 20th century confronting different infectious diseases where there was no other therapy available. Conceivably, this convalescent plasma therapy tends to be proving a game-changing treatment in some COVID-19 patients and could support treatment, in addition to the current interventions before other developed therapies are available for the population.
The Negative Clinical Consequences Due to the Lack of the Elaboration of a Sc...asclepiuspdfs
Until a few years ago, the immune system was considered as responsible for the only defense against microbial infections and other external agents. On the contrary, the immune cells have been proven to be linked not only through cell-cell contact but also by releasing proteins capable of influencing the immune-inflammatory response, the so-called cytokines or interleukins. Moreover, the cytokines have appeared to play not only immune activities but also metabolic and systemic effects influencing the overall biological systems, including the nervous, the endocrine, and the cardiovascular systems, by representing the main endogenous molecules responsible for the maintenance of the unity of the biological life. Therefore, only the systematic clinical consideration of cytokine effects may allow the generation of real future holistic medicine.
The great benefit of blood/blood constitutes therapy is the ability to provide transfusion support for patients with many unique hematologic conditions. For some patients, such as patients with sickle cell disease, thalassemia major, immune hemolytic anemia, anemia of kidney disease, and aplastic anemia may need for this consolidation extends throughout their life. By knowing the alteration mechanisms of these conditions, we can appreciate the stationary, urgency, and the value of the transfused red blood cell (RBC).
Decreasing or Increasing Role of Autologous Stem Cell Transplantation in Mult...asclepiuspdfs
During the past four decades, autologous stem cell transplantation (ASCT) has been the first choice and the standard option for the treatment of newly diagnosed patients with multiple myeloma. The introduction of new agents such as thalidomide, lenalidomide, and bortezomib has led to a clear improvement in basic approach and those agents became the standard of care in the induction phase; however, they were not able to play the role of ASCT in term of progression-free survival and overall survival. Debate continues about the best induction, consolidation, and maintenance taking into account the toxicities of these new agents. The new monoclonal antibody (anti CD38) starts to take its place in the induction setting and it seems to be a promising agent in the high-risk group. Until recently, ASCT is the standard treatment for newly diagnosed patients.
Comparison of the Hypocalcemic Effects of Erythropoietin and U-74389Gasclepiuspdfs
Aim: This study calculated the effects on serum calcium (Ca) levels, after treatment with either of two drugs: The erythropoietin (Epo) and the antioxidant lazaroid (L) drug U-74389G. The calculation was based on the results of two preliminary studies, each one of which estimated the certain influence, after the respective drug usage in an induced ischemia-reperfusion animal experiment. Materials and Methods: The two main experimental endpoints at which the serum Ca levels were evaluated were the 60th reperfusion min (for the Groups A, C, and E) and the 120th reperfusion min (for the Groups B, D, and F). Especially, the Groups A and B were processed without drugs, Groups C and D after Epo administration, whereas Groups E and F after the L administration. Results: The first preliminary study of Epo presented a non-significant hypocalcemic effect by 0.34% ± 0.68% (P = 0.6095). However, the second preliminary study of U-74389G presented a non-significant hypercalcemic effect by 0.14% ± 0.66% (P = 0.8245). These two studies were coevaluated since they came from the same experimental setting. The outcome of the coevaluation was that L is 2.3623042-fold (2.3482723–2.3764196) more hypercalcemic than Epo (P = 0.0000). Conclusions: The antioxidant capacities of U-74389G ascribe 2.3623042-fold more hypercalcemic effects than Epo (P = 0.0000).
The term refractory anemia (RA) may be confusing to those who are not hematologists. RA should be well defined because it means more than what it says. RA is defined as anemia that is not responsive to therapy except transfusion.[1] The term RA is used to rule out those types of anemia with a known cause such as anemia of systemic diseases (liver and kidney) and anemia of inflammation even though they are considered refractory to therapy.[2] RA with cellular or hypercellular bone marrow was formerly used to exclude aplastic anemia.
Management of Immunogenic Heparin-induced Thrombocytopeniaasclepiuspdfs
Immunogenic heparin-induced thrombocytopenia (HIT) is an immune response to heparin associated with significant morbidity and mortality in hospitalized patients if unidentified as soon as possible, due to thromboembolic complications involving both arterial and venous systems. Early diagnoses based on a comprehensive interpretation of clinical and laboratory information improve clinical outcomes. Management principles of strongly suspected HIT should not be delayed for laboratory result confirmation. Treatment strategies have been introduced including new, safe, and effective agents. This review summarizes the clinical therapeutic options for HIT addressing the use of parenteral direct thrombin inhibitors and indirect factor Xa inhibitors as well as the potential non-Vitamin K antagonist oral anticoagulants.
73-year-old woman without any pertinent history was admitted to the hospital due to remittent fever with erythema. She showed itching and linearly arranged erythema on the chest, back, and abdomen [Figure 1a and b]. As she had been taking daily cefditoren pivoxil for the 4 days before her admission, she was diagnosed as having drug-related scratch dermatitis, and the antibiotic treatment was stopped. Her fever remained. Laboratory data showed elevated levels of white blood cells (14,800/μl, normal range 4000–7000) and liver enzymes such as aspartate aminotransferase (AST) 138 IU/L (normal range 5–40), alanine aminotransferase 97 IU/L (normal range 5–35), and ferritin (17469.5 ng/mL, normal range 5–152).
Bone Marrow Histology is a Pathognomonic Clue to Each of the JAK2V617F, MPL,5...asclepiuspdfs
According to the World Health Organization and Clinical Laboratory Molecular and Pathological criteria bone marrow pathology in JAK2V617F mutated trilinear myeloproliferative neoplasm (MPN) patients essential thrombocythemia (ET) and polycythemia vera are indistinguishably featured by clustered medium to large pleomorphic megakaryocytes and increased cellularity (60–90%) due to increased erythropoiesis and megakaryopoiesis. MPL515 mutated ET is the second distinct clonal MPN characterized by thrombocythemia in a normocellular bone marrow showing clustered increased large to giant mature megakaryocytes with staghorn-like hyperlobulated nuclei. Calreticulin (CALR) mutated hypercellular thrombocythemia associated with prefibrotic megakaryocytic, granulocytic myeloproliferation (MGM) recently became the third distinct MPN featured by dense clusters of immature megakaryocytes with cloud-like nuclei. Bone marrow pathology in newly diagnosed MPN patients appears to be a pathognomonic clue for diagnostic differentiation between JAK2V617F mutated trilinear MPN, MPL515 normocellular thrombocythemia, and CALR thrombocythemia with MGM characteristics followed by secondary reticulin fibrosis. Their natural histories clearly differ featured by an increase of erythro/granulopoiesis and cellularity in JAK2V617F, decrease of erythropoiesis and cellularity in MPL515 and increase of dual megakaryo/granulopoiesis and cellularity in CALR mutated MPN.
Helicobacter pylori Frequency in Polycythemia Vera Patients without Dyspeptic...asclepiuspdfs
Introduction: In polycythemia vera (PV) patients, peptic ulcer and gastroduodenal erosions are more common than the general population, but there are insufficient data on the frequency of Helicobacter pylori (HP) and its role in etiopathogenesis. In this study, we aimed to compare the prevalence of HP infection in PV patients without dyspeptic complaints with a healthy control group without dyspeptic complaints. Materials and Methods: Fifty patients with PV without dyspeptic complaints and 50 controls without dyspeptic complaints were enrolled in this study after informed consent obtained. Stool samples of selected patients were analyzed using HP stool antigen test (True Line®). Results: There was surprisingly striking difference between HP prevalence in PV patients without dyspeptic complaints and asymptomatic healthy controls (64% vs. 2%) (P < 0.05). There was no significant relationship found between HP presence and age, gender, treatment modalities, complete blood count, positivity of JAK2 V617F, serum erythropoietin level, and splenomegaly in PV patients (P > 0.05). Conclusion: As the susceptibility of HP infections in PV patients are higher, it is recommended to have close surveillance of these patients by screening HP presence. In addition, when HP positivity is determined, the eradication of HP is essential to prevent possible future gastrointestinal lesions in patients with PV.
Lymphoma of the Tonsil in a Developing Communityasclepiuspdfs
The lymphoma of the tonsil is a rarity. Single case reports have appeared in countries as disparate as China, Greece, India, Japan, and Turkey. Therefore, this paper presents cases found in Nigeria among the Ibo ethnic group. The epidemiological comparisons are deemed to be worthy of documentation such as age ranges and sides of involvement.
Should Metformin Be Continued after Hospital Admission in Patients with Coron...asclepiuspdfs
Background: In most patients with diabetes, guidelines recommend discontinuation of oral anti-diabetic agents. Preliminary data suggest that pre-admission metformin use may have a mortality benefit in patients with coronavirus disease (COVID)-19 admitted to the hospital. Objective: The objective of the study was to review the impact of metformin on morbidity and mortality among hospitalized patients with COVID-19. Methods: Review of English literature by PUBMED search until November 10, 2020. Search terms included diabetes, COVID-19, metformin, retrospective studies, meta-analyses, pertinent reviews, pre-print articles, and consensus guidelines are reviewed.
Clinical Significance of Hypocalcemia in COVID-19asclepiuspdfs
Background: Preliminary data suggest that hypocalcemia is common among patients with COVID-19 admitted to the hospital. Objective: The objective of the study was to examine the clinical significance of hypocalcemia in the setting of COVID-19. Methods: Literature search (PubMed) until August 5, 2020. Search terms include hypocalcemia, COVID-19, mortality, and complications. Retrospective studies are reviewed due to a lack of randomized trials. Results: Prevalence of hypocalcemia among hospitalized patients with COVID-19 ranges from 62% to 78%, depending on the definition of hypocalcemia and patients’ characteristics. In most cases, hypocalcemia is mild to moderate biochemically. Hypocalcemia is a risk factor for hospitalization of patients with COVID-19. In already hospitalized patients, hypocalcemia is significantly associated with increase severity of COVID-19 and its complications, including multiorgan failure, acute respiratory distress syndrome, and death. Hypocalcemia is significantly correlated with inflammatory markers of COVID-19. Causes of hypocalcemia in COVID-19 patients are unclear, but Vitamin D deficiency may be a contributing factor. Conclusion: Hypocalcemia is common in hospitalized patients with COVID-19 and carries unfavorable outcomes. Further studies are needed to examine the causes of hypocalcemia in COVID-19 and to see whether normalization of circulating calcium levels improves prognosis.
Excess of Maternal Transmission of Type 2 Diabetes: Is there a Role of Bioche...asclepiuspdfs
Objective: An excess of maternal transmission of Type 2 diabetes (T2D) has been reported in some populations but not confirmed in other studies. Mitochondrial inheritance has been proposed to explain such excess. In the present paper, we have considered the presence of T2D in the mother and/or in the father in relation to the risk of T2D and to age at onset of the disease in the offspring. The distribution of two genetic polymorphisms involved in glucose metabolism in relation to the presence of T2D in the mother has been also considered. Materials and Methods: Two hundred and seventy-nine participants with T2D were studied in the population of Penne, a small rural town in the eastern side of central Italy. Adenosine deaminase locus 1 (ADA1) and phosphoglucomutase locus 1 (PGM1) phenotypes were determined by starch gel electrophoresis. Statistical analyses were carried out using commercial software (SPSS). Results: The proportion of patients from T2D mothers is much greater as compared to the proportion of the patients from T2D fathers (P < 0.0001). Age at onset of the disease in patients in whom one or both parents are T2D is lower as compared to other patients. The distribution of ADA1 and PGM1 phenotypes in participants with T2D depends on the presence of diabetes in the mother. Conclusions: About the transmission of T2D, our data confirm the high proportion of maternal T2D and show the role of two common biochemical polymorphisms involved in glucose metabolism.
The Effect of Demographic Data and Hemoglobin A 1c on Treatment Outcomes in P...asclepiuspdfs
Objective: Diabetes mellitus, the most common cause of non-traumatic foot amputations, is a life-threatening condition due to its high mortality and morbidity. In our study, we retrospectively evaluated our patients with diabetic foot syndrome in our clinic. Materials and Methods: The demographic data, duration of diabetes, Wagner classification, haemoglobin A 1c (HbA1c) levels, white blood cell, C-reactive protein sedimentation levels, hospital stay, and treatment results were evaluated retrospectively in 14 patients with diabetic foot between January 2017 and December 2018. Results: The mean age of the patients was 62.43 ± 7.7 years. Of the 14 patients, 3 were females and 11 were males. All 14 patients were type 2 diabetes mellitus. When diabetic foot Wagner classification was performed, 6 patients were evaluated as Wagner 2, five patients were Wagner 3, and three patients were evaluated as Wagner 4. Nine patients had complete amputation and 3 had vascular surgery. Conclusion: Although the level of HbA1c is below the target level, the risk of diabetic foot is increased when there is no adequate diabetes mellitus foot training. Inadequate diabetic patient education and hospitalization of patients after infection progress the amputation rate.
Self-efficacy Impact Adherence in Diabetes Mellitusasclepiuspdfs
The aim of the paper is to explore how self-efficacy (SE) is associated with adherence among adults with diabetes mellitus (DM). Methods: The search of electronic databases identified 564 records from 2007 to 2017 on SE and adherence from different perspectives and its effect on adults with DM. Discussions: SE increases the confidence in adults in their self-care behaviors. Non-adherence continues to be a significant barrier to SE. SE and adherence should be informed by an understanding of theoretical frameworks and the individual characteristics. Conclusion: Adherence is likely among adults with better SE to empower them to make valid decisions about their health. Interventions to improve SE should be tailored based on different types of non-adherence such as intentional and unintentional non-adherence. Implications: An intercollaborative professional practice approach is crucial to improve SE and adherence for sound judgment and valid decision-making.
Uncoiling the Tightening Obesity Spiralasclepiuspdfs
While an underweight prevalence was once more than twice that of obesity, now more people are obese than underweight. Obesity is one of the leading causes of preventable death in the world. There are an estimated 2,100,000,000 obese people worldwide and that number is forecast to grow to 51% of the world’s population by 2030. Escalating obesity-related disease costs threaten to bankrupt the world’s health-care systems.
Prevalence of Chronic Kidney disease in Patients with Metabolic Syndrome in S...asclepiuspdfs
Background and Objective: Chronic kidney disease (CKD) which is an increasingly important clinical and public health issue is associated with cardiovascular disease. Epidemiologic studies have also linked metabolic syndrome (MetS) with an increased risk of incident CKD. Therefore, the present study was designed retrospectively to find the prevalence and potential risk factors of CKD in patients with MetS in Saudi Arabia.
Management Of Hypoglycemia In Patients With Type 2 Diabetesasclepiuspdfs
Hypoglycemia is the rate-limiting step of intensive management in patients with diabetes. Lowering one’s A1C to a prescribed target is expected to mitigate one’s risk of developing long- and short-term diabetes-related complications. Several of the less expensive and commonly prescribed glucose lowering agents favored by practitioners result in weight gain, hypoglycemia, and even an increased risk of cardiovascular (CV) mortality. Although achieving a targeted A1C of <7 % is the standard of care, clinicians often fail to evaluate patients for glycemic variability which can increase oxidative stress driving long-term diabetes-related complications including CV death. The use of concentrated insulins and glucagon-like peptide-1 receptor agonists separately or in combination with each other reduces glycemic variability and one’s risk of hypoglycemia. Pharmaceutical agents which allow patients to safely achieve their targeted A1C without weight gain and hypoglycemia should be preferred in patients with type 2 diabetes.
Predictive and Preventive Care: Metabolic Diseasesasclepiuspdfs
South Asians have a very high incidence of ischemic heart disease and stroke. In addition, they also have a very high incidence of metabolic diseases such as prehypertension, hypertension, visceral obesity, metabolic syndrome, prediabetes, type-2 diabetes, and its clinical complications. Currently, there are over 75 million diabetic subjects in India and an equal number of prediabetics. Republic of China has taken over India as the diabetes capital of the world, with over 115 million diabetics. Modern medicine is disease focused and has failed to address the prevention of these chronic diseases. According to the reports from the United Nations (Millennium Development Goals [MDGs], the World Health Organization, Global Health Initiatives, and the non-communicable disease risk task force), obesity has increased by 2-fold and type-2 diabetes by 4-fold worldwide. Experts in this field predict that chances of meeting the MDGs set by the UN members of reducing the incidence of these diseases at 2025 to the level of 2020 are very little. Western medicine has failed to reduce or reverse the trend in the incidence of these diseases. We feel that an integrated approach to health care may be a better option, to reduce the disease burden in developing and resource-poor countries. Having said that, one cannot prevent something that one is not aware of, as such it is the need of the hour for us, to develop a robust predictive and preventive health-care platform. In an earlier article, we presented our views on reducing or reversing cardiometabolic diseases. There is great enthusiasm among the health-care providers and professional bodies that integration of emerging technologies will help develop personalized, precision medicine, as well as reduce the cost of health-care worldwide.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
2. Bloom and Tavrow: Domestic Violence Screening By Primary Care Clinicians
2 Journal of Community and Preventive mediCine • Vol 1 • Issue 2 • 2018
substance use, suicidal ideation, irritable bowel syndrome,
sexually transmitted infections, pregnancy complications,
and other health complaints.[4-7]
Since victims may not
disclose DV unprompted, primary care clinicians need to
screen them for DV as the initial step in identifying them
and helping them to obtain supportive services. The relative
privacy, safety, and professionalism of a clinician’s office can
put victims at ease, thus giving providers a unique opportunity
to discover nascent or chronic abuse, intimidation, or fear.
Studies indicate that screening for DV leads to increased
identification of victims in many health-care settings
including emergency rooms, obstetrics and gynecology,
prenatal care settings, and primary care settings.[8-13]
Mandating universal screening for DV in health-care settings
has been controversial in the US Health Care System since
it was first proposed in the 1980s.[14]
Beginning in 1999,
major organizations have been advocating for routine or
universal DV screening, including Futures Without Violence,
the American College of Obstetricians and Gynecologists,
and the Centers for Disease Control and Prevention.[15-18]
In
2013, the US Preventive Services Task Force recommended
that clinicians screen women of childbearing age for DV
and provide intervention services or referrals to women who
screen positive.[19]
Due to a limited evidence base on the
effects of screening, this recommendation is currently under
review.
To date, DV screening has not been universally integrated
into health-care settings in the US.A nationally representative
telephone survey of 4821 adult women found that only
7% reported ever being screened for DV in a health-care
setting.[20]
Providers resist universal screening for numerous
reasons, including lack of training in DV, discomfort with the
topic, fear of offending patients, concern about mandatory
reporting requirements, or time-related concerns.[4,21-23]
Researchers have also documented clinic-level barriers,
such as having inadequate administrative or management
support for victims once they are identified, not having a set
protocol for screening or referrals, and being required to keep
consultations brief.[21,24]
In addition, providers may not screen
patients if they feel it is not part of their job or not a problem
among the populations they serve.[25,26]
Although DV affects women of all backgrounds,
studies suggest that some people, such as those of lower
socioeconomic status, may experience more DV.[27-29]
For
instance, a multistate study found that an annual income
of less than $25,000 was strongly associated with DV.[30]
Women who have less education or are divorced/separated
also appear to experience higher rates of DV.[29,31]
Those
patients who present to providers with two or more physical
symptoms (e.g., tiredness, chest pain, and diarrhea), physical
injuries (e.g., bruising, ruptured eardrums, or have patterns of
repeated injury), post-traumatic stress disorder, or depression
also are more likely to be experiencing DV.[29,32-34]
In some areas of primary care, researchers have detected
an implicit bias in how clinicians treat low-income patient
populations (LIPPs) as compared to higher-income patient
populations (HIPPs).[35]
Implicit bias refers to the attitudes
or stereotypes that affect our understanding, actions, and
decisions in an unconscious manner.[36]
Implicit bias related
to socioeconomic status may explain why providers are less
likely to recommend that LIPPs sign up for breast cancer
screening, enroll in prenatal care, or undergo Papanicolaou
tests.[37-41]
Moreover, researchers have noted that physicians
frequently presume that LIPPs have lower self-control and
less ability to change negative health behaviors than higher
income patients.[42]
However, research about potential
provider biases in screening for DV has been limited. A 2008
study found that health care providers screened for DV more
often among African Americans whose annual incomes were
less than $25,000 as compared to those with higher incomes,
but this same pattern was not seen among patients who
were not African-American, indicating biases in screening
behaviors.43
In this study, our goal is to determine whether implicit bias
related to the income level of patient populations is affecting
primary care practitioners’ DV screening and identification
in California. We will assess whether health-care providers
working with predominantly LIPPs report significantly
different DV screening practices and outcomes as compared
to those working with HIPPs. We also will seek to determine
which factors seem most predictive of whether a provider
identifies DV victims.
MATERIALS AND METHODS
This study is based on data from a cross-sectional survey
of health-care providers, mostly based in California.[44]
To
be eligible for the study, health-care providers needed to
be clinicians (physicians, nurse practitioners, physician
assistants, or nurses), currently practicing in a primary care
setting and seeing female patients aged 15 or older.
Data were collected between October 2013 and March 2014
in Southern California using three different recruitment
mechanisms. The first mechanism entailed requesting
directors from three professional provider networks to
forward the survey link to their providers through email.
The second mechanism involved administering the survey to
health-care providers from Safety Net Clinics in Los Angeles
before one hour training on DV. All training participants were
asked to self-complete the paper survey. The third mechanism
consisted of approaching individual providers over 2 days
at the 2014 Annual PriMed Conference West, a regional
conference for primary care and family practice clinicians
held in Anaheim, California. All PriMed participants
3. Bloom and Tavrow: Domestic Violence Screening By Primary Care Clinicians
Journal of Community and Preventive mediCine • Vol 1 • Issue 2 • 2018 3
self-administered the paper survey. No participants received
direct compensation for participating in the survey but could
elect to enter their information into a raffle for a gift card
of nominal value. Overall, 191 providers took the survey, of
whom 11 completed it online and 180 self-administered the
survey through paper in-person. For this study, we extracted
the 152 providers who indicated they worked in primary care
and had provided information on the predominant income of
their patient populations, which is our focus.
The survey, designed to take 8–10 minutes, included
quantitative and qualitative questions. Quantitative questions
captured providers’demographics, patient profiles, screening
frequencies and practices, past training, confidence in
assisting DV survivors, and how many DV survivors they
identified in the past month. Qualitative questions included
asking providers to record what first question they would
normally ask when screening for DV, where they might refer
a DV victim, and what specific DV code (if any) they used in
electronic medical records.
Variables were operationalized as follows. For the income
of their patient population, providers had been asked if they
primarily served low-income populations, to which they
could respond “yes,” “no,” or “don’t know.” Those who
answered “don’t know” were excluded from the analysis.
Providers who responded “yes” were categorized as working
with LIPPs, and those who responded “no” were categorized
as working with HIPPs. For questions on how often providers
screen for DV, they were given five options: “always,” “most
of the time,” “sometimes,” “rarely,” or “never.” During
regression analysis, this screening variable was dichotomized
into “always or most of the time” and “sometimes, rarely,
or never.” Our outcome variable, the number of DV victims
identified in the last 30 days, was also collapsed into two
categories (none vs. one or more) for logistic regression
analysis, because we wished to predict identification of any
victims.
Open-ended questions were grouped into categories and
cross-checked for interrater reliability. Regarding the
training they had received in DV, providers’ responses were
categorized as pre-service training (i.e., while in professional
school), in-service training (i.e., at the workplace or
through continuing education), both, or none. Providers
gave many responses to the question, “At what age do you
begin screening for DV?” Their responses were coded and
categorized as: “any time” indicating that age did not matter
to the physician when screening; “less than 18 years old”
indicating that the provider gave a specific age or age range
under 18; “18 years or older” indicating that the provider
said 18 or a higher age; and “no response” indicating that
the provider did not respond to the question. Regarding the
first question that a provider used for DV screening, for any
question written the provider was given a code of “1.” If the
answer was left blank, they were given a “0.”
Finally, we created a “universal screening” index from
three screening practice questions to estimate the extent of
recommendedscreening.Thethreeitemsincludedwere:(a)Start
to screen female patients before the age of 18; (b) screen female
patients “always or most of the time;” and (c) able to record an
initial screening question used.These items all have face validity
and correlated with the outcome. Providers with higher index
scores were more regularly engaging in recommended screening
practices.
Data were entered into SPSS 25 and analyzed. Bivariate
comparisons were conducted of providers serving
predominantly low-income and higher-income populations.
Then we performed logistic regression analysis to determine
predictors of reported identification of DV victims. Finally,
we carried out ANOVA analysis to assess the impact of the
universal screening index on victim identification by patient
population type.
RESULTS
Of the 152 primary care providers included in the analysis,
98 (64%) worked primarily with LIPPs and most (90.7%)
worked in California [Table 1]. Two-thirds of the providers
were female and about half were older than 50. There were
slightly more physician assistants, nurse practitioners, and
nurses (54.6%) than physicians (45.4%). About one-third of
participants had not received any training on DV, while nearly
20% had received both in-service and pre-service training.
Regarding provider demographics, the only significant
difference by patient income level was the number of years
that a provider had been in practice: Those working with
LIPPs were considerably more likely to have been in practice
10 years or less (45.9%) as compared to those working with
HIPPs (17%) (P 0.01).
In contrast, DV screening practices and outcomes varied
significantly by the income level of the provider’s patients
[Table 2]. More than half of providers working with LIPPs
reported screening always or most of the time, as compared
to only 18.9% of providers working with HIPPs (P 0.01).
Those working with LIPPs were more likely to start screening
their patients at ages 18 or younger (46.5% vs. 26.4%), able
to provide a screening question (92.9% vs. 77.4%), and state
a specific code for documenting DV in electronic medical
records (45.5% vs. 22.6%) (all P 0.01). Our “universal
screening” index revealed that 40.4% of the providers
working with LIPPs engaged in all three recommended
screening practices, as compared to only 13.2% of providers
working with HIPPs (P 0.01). Regarding DV outcomes,
about half of all providers knew a specific place to refer DV
victims. However, those working with LIPPs were more than
twice as likely to report having identified at least one DV
4. Bloom and Tavrow: Domestic Violence Screening By Primary Care Clinicians
4 Journal of Community and Preventive mediCine • Vol 1 • Issue 2 • 2018
victim in the past month (52.6% vs. 22.7%) (P 0.01).
To determine the predictors for identifying DV victims in the
past 30 days, we conducted logistic regression analysis. The
six predictors we tested were gender (male vs. female), how
many years providers had been in practice (three categories),
whether they had received any DV training, if they knew
where to refer someone who was experiencing DV, their score
on the “universal screening” index, and whether they worked
with LIPPs. As shown in Table 3, two of these predictors
were found to be significantly associated with identifying one
or more DV victims: score on universal screening practices
(adjusted odds ratio [AOR] = 1.62) and working with LIPPs
(AOR=3.14) (both P 0.01).
UsingANOVA, we further tested the impact of our “universal
screening” index on whether DV victims were identified.
We found that providers working with LIPPs completed
significantly more screening activities on average to identify
one or more DV victims than those working with HIPPs
(2.29 vs. 1.75 activities, respectively) [Table 4]. Overall,
it took on average 1.84 screening activities to identify one
or more DV victims, regardless of income of clinic setting
(P 0.01).
DISCUSSION
Even though female patients do not mind being screened for
DV, this study found that only 31% of primary care providers
engaged in recommended universal screening practices.[45]
Particularly striking were differences by patient population
income, with just 13% of providers serving higher-income
patients reporting regular screening of adolescent girls and
women, as compared to 40% of those serving low-income
patients. We suggest that this result reveals an implicit
provider bias that higher income patients would not benefit
from DV screening, since providers of both patient income
types had equivalent DV training and referral knowledge.
Other possible explanations are that providers feel less
comfortable screening women from a similar socioeconomic
stratum or that clinics serving LIPPs are more likely to have
on-site social workers who can facilitate referrals.
Our research also confirms that regular DV screening of all
adolescents and adult women in primary care would yield
Table 1: Demographics of primary health‑care providers by predominant income of their clinic’s patients
Characteristics LIPPs n=99 (%) HIPPs n=53 (%) Total n=152 (%) P
Age 0.270
30 or younger 8 (8.2) 4 (7.5) 12 (7.9)
31‑50 44 (44.9) 17 (32.1) 61 (40.4)
51 or older 46 (46.9) 32 (60.4) 78 (51.7)
Sex 0.066
Male 28 (28.6) 23 (43.4) 51 (33.8)
Female 70 (71.4) 30 (56.6) 100 (66.2)
Works in California 0.228
Yes 90 (92.8) 46 (86.8) 136 (90.7)
No 7 (7.2) 7 (13.2) 14 (9.3)
Occupation 0.178
Physician 41 (41.4) 28 (52.8) 69 (45.4)
NP, PA, nurse, other 58 (58.6) 25 (47.2) 83 (54.6)
Total years in clinical practice 0.000
10 years 45 (45.9) 9 (17.0) 54 (35.8)
11–20 years 15 (15.3) 21 (39.6) 36 (23.8)
21 years or more 38 (38.8) 23 (43.4) 61 (40.4)
Received training in DV 0.828
Pre‑service and in‑service training 21 (21.2) 8 (15.1) 29 (19.1)
Pre‑service only 18 (16.2) 10 (18.9) 26 (17.1)
In‑service only 32 (32.3) 18 (34.0) 50 (32.9)
No training 30 (30.3) 17 (32.1) 47 (30.9)
All data are presented as n (%). NP: Nurse practitioner; PA: Physician’s assistant. LIPPs: Low‑income patient populations,
HIPPs: Higher‑income patient populations, DV: Domestic violence
5. Bloom and Tavrow: Domestic Violence Screening By Primary Care Clinicians
Journal of Community and Preventive mediCine • Vol 1 • Issue 2 • 2018 5
more detection of those experiencing DV.[8,10,11,13]
Unlike
previous studies, provider’s gender and prior DV training
did not predict whether they reported having detected DV
victims in the past month.[44,46-47]
Only two variables, universal
screening and working with mainly low-income patients,
predicted primary care providers’ reported identification of
one or more DV victims. A potential advantage of engaging
in universal screening practices in primary care settings, as
compared to emergency rooms or in specialized services,
is that it increases the likelihood that a clinician would be
able to assist victims to obtain services when the DV is still
in its incipient stage. This could reduce physical injury and
psychological suffering of victims. Moreover, primary care is
more readily accessible to patient populations of all incomes
and therefore is a good entry point for adolescents and
women who might not know what kinds of services might be
available to them.
While it does seem likely that women of lower socioeconomic
statusexperiencemoreDV,asnotedearlier,thisstudysuggests
that if providers adopted universal screening practices for all
women, more women of higher income suffering from DV
would be identified. It is noteworthy that the study found
that only 1.75 screening activities were required on average
to detect a higher income DV victim, as compared to 2.29
screening activities for a lower income victim. Alternatively,
the higher number of screening activities required per low-
income patient identified could relate to a higher level of
Table 2: Reported primary health‑care provider screening practices and outcomes by predominant income of
their clinic’s patients
Screening Practices and Outcomes LIPPs n=99 (%) HIPPs n=53 (%) Total n=152 (%) P
How often screens for DV 0.000
Always, most of the time 52 (52.5) 10 (18.9) 62 (40.8)
Sometimes, rarely, or never 47 (47.5) 43 (81.1) 90 (59.2)
Age begins screening females for DV 0.003
Any time (age doesn’t matter) 19 (19.2) 5 (9.4) 24 (15.8)
18 years old 46 (46.5) 14 (26.4) 60 (39.5)
18 years or older 25 (25.3) 20 (37.7) 45 (29.6)
No response 9 (9.1) 14 (26.4) 23 (15.1)
Can provide a first screening question 0.006
Yes 92 (92.9) 41 (77.4) 133 (87.5)
No 7 (7.1) 12 (22.6) 19 (12.5)
Does all the above (universal screening)1
0.000
Yes (all 3 items) 40 (40.4) 7 (13.2) 47 (30.9)
Partial (1–2 items) 53 (53.6) 35 (66.0) 88 (57.9)
No (0 items) 6 (6.1) 11 (20.8) 17 (11.2)
Uses specific code for documenting DV 0.006
Yes 45 (45.5) 12 (22.6) 57 (37.5)
No 54 (54.5) 41 (77.4) 95 (62.5)
Knows where to refer DV victim 0.984
Yes, knows specific place (s) or person (s) 54 (54.5) 29 (54.7) 83 (54.6)
Doesn’t know or gives vague response 45 (45.9) 24 (45.3) 69 (45.4)
Reported number of DV victims identified in the
last 30 days
0.001
None 47 (47.5) 41 (77.4) 88 (57.9)
1–2 victims 39 (39.5) 11 (20.8) 50 (32.9)
3 or more victims 13 (13.1) 1 (1.9) 14 (9.2)
All data are presented as n (%). DV=Intimate Partner Violence; 1
“Universal screening” = (1) screens always or most of the time, (2) starts
screening before age 18, and (3) could provide interviewer with a first screening question. Maximum score is 3. LIPPs: Low‑income patient
populations, HIPPs: Higher‑income patient populations. DV: Domestic violence
6. Bloom and Tavrow: Domestic Violence Screening By Primary Care Clinicians
6 Journal of Community and Preventive mediCine • Vol 1 • Issue 2 • 2018
inherent biases in the recruitment of providers. In addition,
the study did not collect any data on the race or ethnicity
of either the providers who participated in the study or of
the patients they served. It is possible, as documented in the
literature, that providers’ screening practices were influenced
by the race or ethnicity of their patients and not just their
income level.[38,43]
It is also possible that providers were more
or less likely to screen based on whether their patients were
of the same race or ethnicity as themselves. These issues
require additional research. Finally, there were limitations
related to the self-report measures used. Some providers may
have overstated the frequency of their screening practices
due to social desirability. By creating the universal screening
index, we were able to triangulate information to improve
accuracy. Ultimately, however, we had to rely on what the
health-care providers disclosed to us, as there is no way to
authenticate much of the information we collected based on
their responses.
CONCLUSIONS
Implicit bias may explain why primary health-care providers
serving low-income populations self-reported significantly
more DV screening activities, despite having similar levels
of DV training as other providers. As is the case with other
occurrences of implicit bias, providers should be encouraged
to engage in self-reflection and peer appraisal to determine if
they are unconsciously presuming that DVis a problem mainly
or exclusively in LIPPs. Continuing education in DVscreening
could help providers identify and correct this implicit bias.
Health facility administrators may also harbor this implicit
bias, which could be influencing clinic procedures. They, too,
may need to engage in self-reflection and appraisal of their
practices. This study confirmed that more DV screening leads
to more identification. Currently, the majority of primary care
providers are not engaging in universal screening. To promote
screening and referrals, written policies and standardized
procedures should be in place, with visible reminders present
throughout the facility.[50]
Providers need to be aware that DV
distrust of doctors, as was found by Armstrong et al.[48]
In
low-income clinics, having the same health-care provider is
uncommon, due to staff turnover.[49]
Not obtaining continuity
of care from the same primary health-care provider may be a
barrier in building a trusting relationship with a provider and
might discourage disclosure of DV. If undocumented, these
patients may also have greater fears of deportation or income
loss if they speak out. These barriers may therefore require
additional energy from health-care providers working with
LIPPs to encourage disclosure. The opposite may be true
with HIPPs. Patients with higher incomes may have more
trusting relations with their health-care providers and feel
more comfortable disclosing sensitive information if they are
given the opportunity to do so.
This study had several limitations. As a convenience sample,
it is possible that this study did not accurately represent
the screening practices of primary health-care providers in
California. However, the researchers are unaware of any
Table 3: Predictors of reported identification of
any DV victim in the last 30 days, using logistic
regression (n=151)
Predictors Results
Variables” One or more victims
identified
AOR2
CI 95%
Female provider 0.97 (0.44, 2.14)
Total years in practice 1.36 (0.90, 2.08)
Received DV training 1.99 (0.85, 4.65)
Knew where to refer 0.86 (0.41, 1.83)
Did universal screening1
1.62 (1.06, 2.45)
Works in a low‑income clinic 3.14 (1.34, 7.32)
1
Universal screening index= (1) screens always or most of the
time, (2) starts screening before age 18, and (3) could provide
interviewer with a first screening question. Maximum score
is 3. 2
Adjusted for all items listed. LIPPs: Low‑income patient
populations, HIPPs: Higher‑income patient populations. DV:
Domestic violence, AOR: Adjusted odds ratio, CI: Confidence
interval
Table 4: Reported number of DV victims identified, by mean universal screening index1
and predominant
income of their clinic’s patients, using ANOVA
Number of
DV victims
identified
LIPPs (n=99) HIPPs (n=53) Total (n=152) F‑value (sig.)
25.4 (0.000)
None 1.91 1.20 1.58
One or more 2.29 1.75 2.19
Total 2.11 1.32 1.84
1
Universal screening index= (1) screens always or most of the time, (2) starts screening before age 18, and (3) could provide interviewer
with a first screening question. Maximum score is 3. LIPPs: Low‑income patient populations, HIPPs: Higher‑income patient populations.
DV: Domestic violence
7. Bloom and Tavrow: Domestic Violence Screening By Primary Care Clinicians
Journal of Community and Preventive mediCine • Vol 1 • Issue 2 • 2018 7
screening can help all women to disclose an unsafe home
environment, which can be an important first step in getting
supportive services.
DECLARATIONS
This study received ethical approval from the Institutional
Review Board #13-001626 of the UCLA. All participants
provided their written consent before participating in the
study.
COMPETING INTERESTS
Neither author has any financial nor non-financial competing
interests.
FUNDING INFORMATION
Brittnie E. Bloom and Paula Tavrow did not receive any
financial support for this work.
ACKNOWLEDGMENTS
The authors are grateful to Mellissa Withers and Stephanie
Albert for their contributions to survey construction and data
collection.
REFERENCES
1. National Coalition Against Domestic Violence. Domestic
Violence National Statistics. Published 2015. Available from:
https://www.speakcdn.com/assets/2497/domestic_violence.
pdf.[Last accessed on 2018 Mar 09].
2. Boyle A, Yong MA. Clinical Effectiveness Committee:
Guidelines for the Recognition and Management of Domestic
Violence in Emergency Departments. Excellence in Emergency
Care. Published 2010. Available from: https://www.secure.
rcem.ac.uk/code/document.asp?ID=4679. [Last accessed on
2018 Mar 09].
3. National Center for Injury Prevention and Control. Costs of
Intimate Partner Violence Against Women in the United States.
Atlanta (GA): Centers for Disease Control and Prevention.
Published 2003. Available from: https://www.cdc.gov/
violenceprevention/pdf/IPVBook-a.pdf. [Last accessed on
2018 Mar 09].
4. Ellis JM. Barriers to effective screening for domestic violence
by registered nurses in the emergency department. Crit Care
Nurs Q 1999;22:27-41.
5. Campbell J, Kub JE, Rose L. Depression in battered women.
J Am Med Womens Assoc (1972) 1996;51:106-10.
6. O’Doherty L, Hegarty K, Ramsay J, Davidson LL, Feder G,
Taft A, et al. Screening women for intimate partner violence
in healthcare settings. Cochrane Database Syst Rev
2015;7:CD007007.
7. U.S. Department of Health and Human Services. Intimate
Partner Violence: Consequences. Atlanta (GA): Centers
for Disease Control and Prevention. Published 2014.
Available from: https://www.cdc.gov/violenceprevention/
intimatepartnerviolence/consequences.html. [Last accessed on
2018 Mar 09].
8. Krimm J, Heinzer MM. Domestic violence screening in the
emergency department of an urban hospital. J Natl Med Assoc
2002;94:484-91.
9. Ahmad I, Ali PA, Rehman S, Talpur A, Dhingra K. Intimate
partner violence screening in emergency department: A rapid
review of the literature. J Clin Nurs 2017;26:3271-85.
10. DuncanMM,McIntoshPA,StaytonCD,HallCB.Individualized
performance feedback to increase prenatal domestic violence
screening. Mater Child Health J 2006;10:443-9.
11. Naumann P, Langford D,Torres S, Campbell J, Glass N.Women
battering in primary care practice. Fam Pract 1999;16:343-52.
12. McFarlane J, Christoffel K, Bateman L, Miller V, Bullock L.
Assessing for abuse: Self-report versus nurse interview. Public
Health Nurs 1991;8:245-50.
13. Freund KM, Bak SM, Blackhall L. Identifying domestic
violence in primary care practice. J Gen Intern Med
1996;11:44-6.
14. Phelan MB. Screening for intimate partner violence in medical
settings. Trauma Violence Abuse 2007;8:199-213.
15. Nelson HD, Bougatsos C, Blazina I. Screening women for
intimate partner violence: A systematic review to update the
U.S. Preventive services task force recommendation. Ann
Intern Med 2012;156:796-808, W-279, W-280, W-281, W-282.
16. Moyer VA, U.S. Preventive Services Task Force. Screening for
intimate partner violence and abuse of elderly and vulnerable
adults: U.S. Preventive services task force recommendation
statement. Ann Intern Med 2013;158:478-86.
17. The American College of Obstetricians and Gynecologists.
Intimate Partner Violence. Published 2012. Available from:
https://www.acog.org/Clinical-Guidance-and-Publications/
Committee-Opinions/Committee-on-Health-Care-for-
Underserved-Women/Intimate-Partner-Violence. [Last accessed
on 2018 Mar 09].
18. Futures Without Violence. IPV Screening and Counseling
Toolkit. Published 2013. https://www.futureswithoutviolence.
org/ipv-screening-and-counseling-toolkit/. [Last accessed on
2018 Mar 09].
19. U.S. Preventive Services Task Force. Final Recommendation
Statement: Intimate Partner Violence and Abuse of Elderly
and Vulnerable Adults. Published 2016. Available from:
https://www.uspreventiveservicestaskforce.org/Page/
Document/RecommendationStatementFinal/intimate-
partner-violence-and-abuse-of-elderly-and-vulnerable-adults-
screening#consider. [Last accessed on 2018 March 09].
20. Klap R, Tang L, Wells K, Starks SL, Rodriguez M. Screening
for domestic violence among adult women in the United States.
J Gen Intern Med 2007;22:579-84.
21. Natan MB, Ari GB, Bader T, Hallak M. Universal screening
for domestic violence in a department of obstetrics and
gynaecology: A patient and career perspective. Int Nurs Rev
2013;59:108-14.
22. Harwell TS, Casten RJ, Armstrong KA, Dempsey S,
Coons HL, Davis M, et al. Results of a domestic violence
training program offered to the staff of urban community health
centers. Evaluation committee of the Philadelphia Family
Violence Working Group. Am J Prev Med 1998;15:235-42.
8. Bloom and Tavrow: Domestic Violence Screening By Primary Care Clinicians
8 Journal of Community and Preventive mediCine • Vol 1 • Issue 2 • 2018
How to cite this article: Bloom BE, Tavrow P. Are
Primary Care Clinicians Serving Low Income Patients
More Likely to Screen for Domestic Violence?.
J Community Prev Med 2018;1(2):1-8
23. Gerbert B, Gansky SA, Tang JW, McPhee SJ, Carlton R,
Herzig K, et al. Domestic violence compared to other health
risks: A survey of physicians’ beliefs and behaviors. Am J Prev
Med 2002;23:82-90.
24. Davis RE, Harsh KE. Confronting barriers to universal
screening for domestic violence. J Prof Nurs 2001;17:313-20.
25. Todahl J, Walters E. Universal screening for intimate
partner violence: A systematic review. J Marital Fam Ther
2011;37:355-69.
26. Chamberlain L, Perham-Hester KA. The impact of perceived
barriers on primary care physicians’ screening practices for
female partner abuse. Women Health 2002;35:55-69.
27. Cunradi C, Caetano R, Schafer J. Socioeconomic predictors
of intimate partner violence among white, black and hispanic
couples in the United States. J Fam Violence 2002;17:377-89.
28. Kramer A, Lorenzon D, Mueller G. Prevalence of intimate
partner violence and health implications for women using
emergency departments and primary care clinics. Womens
Health Issues 2004;14:19-29.
29. Hegarty K, Gunn J, Chondros P, Taft A. Physical and social
predictors of partner abuse in women attending general practice:
A cross-sectional study. Br J Gen Pract 2008;58:484-7.
30. Vest JR, Catlin TK, Chen JJ, Brownson RC. Multistate analysis
of factors associated with intimate partner violence. Am J Prev
Med 2002;22:156-64.
31. McCauley J, Kern DE, Kolodner K, Dill L, Schroeder AF,
DeChant HK, et al. The “battering syndrome”: Prevalence and
clinical characteristics of domestic violence in primary care
internal medicine practices. Ann Intern Med 1995;123:737-46.
32. Power C. Domestic violence: What can nurses do? Aust Nurs J
2004;12:21-3.
33. Ulrich YC, Cain KC, Sugg NK, Rivara FP, Rubanowice DM,
Thompson RS, et al. Medical care utilization patterns in
women with diagnosed domestic violence. Am J Prev Med
2003;24:9-15.
34. Duxbury F. Recognising domestic violence in clinical practice
using the diagnoses of posttraumatic stress disorder, depression
and low self-esteem. Br J Gen Pract 2006;56:294-300.
35. Fiscella K, Franks P, Gold MR, Clancy CM. Inequality
in quality: Addressing socioeconomic, racial, and ethnic
disparities in health care. JAMA 2000;283:2579-84.
36. FitzGerald C, Hurst S. Implicit bias in healthcare professionals:
A systematic review. BMC Med Ethics 2017;18:19.
37. O’Malley MS, Earp JA, Hawley ST, Schell MJ, Mathews HF,
Mitchell J, et al. The association of race/ethnicity,
socioeconomic status, and physician recommendation for
mammography: Who gets the message about breast cancer
screening? Am J Public Health 2001;91:49-54.
38. Bao Y, Fox SA, Escarce JJ. Socioeconomic and racial/
ethnic differences in the discussion of cancer screening:
“Between”versus “within-” physician differences. Health Serv
Res 2007;42:950-70.
39. PotoskyAL, BreenN, GraubardBI,Parsons PE.Theassociation
between health care coverage and the use of cancer screening
tests. Results from the 1992 National Health Interview Survey.
Med Care 1998;36:257-70.
40. Hahn RA, Teutsch SM, Franks AL, Chang MH, Lloyd EE.
The prevalence of risk factors among women in the United
States by race and age, 1992-1994. J Am Med Womens Assoc
1998;53:96-104.
41. McDonald TP, Coburn AF. Predictors of prenatal care
utilization. Soc Sci Med 1988;27:167-72.
42. van Ryn M, Burke J. The effect of patient race and socio-
economic status on physicians’perceptions of patients. Soc Sci
Med 2000;50:813-28.
43. Weeks EK, Ellis SD, Lichstein PR, Bonds DE. Does health
care provider screening for domestic violence vary by race and
income? Violence Against Women 2008;14:844-55.
44. Tavrow P, Bloom BE, Withers MH. Intimate partner violence
screening practices in California after passage of the affordable
care act. Violence Against Women 2016; 23: 871-86 .
45. Bacchu L, Mezey G, Bewley S. Women’s perceptions and
experiences of routine enquiry for domestic violence in a
maternity service. BJOG 2002;109:9-16.
46. Tower LE. Barriers in screening women for domestic
violence: A survey of social workers, family practitioners, and
obstetrician-gynecologists. J Fam Violence 2006;21:245-57.
47. Waalen J, Goodin MM, Spitz AL, Peterson R, Saltzman LE.
Screening for intimate partner violence by health care
providers. Am J Prev Med 2000;19:230-7.
48. Armstrong K, Ravenell KL, McMurphy S, Putt M. Racial/
ethnic differences in physician distrust in the United States.
Am J Public Health 2007;97:1283-9.
49. Becker G, Newsom E. Socioeconomic status and dissatisfaction
with health care among chronically ill African Americans. Am
J Public Health 2003;93:742-8.
50. Allen NE, LehrnerA, Mattison E, Miles T, RusselA. Promoting
systematic change in the health care response to domestic
violence. J Community Psychol 2007;36:103-20.